{
  "url": "https://openlegislation.uk/eu-decision-2002-106/annex/chapter-VII/division-B/division-6",
  "json_url": "https://openlegislation.uk/eu-decision-2002-106/annex/chapter-VII/division-B/division-6.json",
  "legislation": "eudn/2002/106",
  "legislation_title": "2002/106/EC: Commission Decision of 1 February 2002 approving a Diagnostic Manual establishing diagnostic procedures, sampling methods and criteria for evaluation of the laboratory tests for the confirmation of classical swine fever (Text with EEA relevance) (notified under document number C(2002) 381)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2002-106",
  "path": "annex/chapter/VII/division/B/division/6",
  "kind": "division",
  "number": "6",
  "heading": null,
  "text": "Quality control on sensitivity and specificity of each batch of an ELISA must be regularly performed by the national laboratory, making use of a panel of reference sera .... This panel shall include:\nsera from pigs in the early phase of classical swine fever virus infection (before 21 days post infection);\nsera from convalescent pigs (after 21 days post infection);\nsera from pigs infected with ruminant pestiviruses.\nThe ELISA to be used for the serological diagnosis of classical swine fever must recognise all reference sera from the convalescent pigs. All results obtained with the reference sera must be repeatable. It is further recommended that they detect all positive sera from the early phase and to show a minimum of cross-reactions with the sera from pigs infected with ruminant pestiviruses.\nThe results obtained with the reference sera from pigs in the early phase of infection give an indication of the sensitivity of the ELISA.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Word in Annex Ch. 7 Section B para. 6 substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 7(8)(c)(i); 2020 c. 1, Sch. 5 para. 1(1)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Annex Ch. 7 Section B para. 6 substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 7(8)(c)(ii); 2020 c. 1, Sch. 5 para. 1(1)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in Annex Ch. 7 Section B para. 6 omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 7(8)(c)(iii); 2020 c. 1, Sch. 5 para. 1(1)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2002/106/annex/chapter/VII/division/B/division/6",
    "retrieved_at": "2026-11-01T15:18:36.246374+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}